Pharmaron and Vaccitech have announced that they have entered into a Strategic Partnership for Development and cGMP Manufacturing Services for Vaccitech’s Adenoviral Vector programme. Pharmaron will become a key part of Vaccitech’s manufacturing network to support novel T cell immunotherapeutics and vaccines from its proprietary ChAdOx1 viral vector platform. Source: BIA News 9/2/2023